Kilis 7 Aralık University, School of Health Services
Kilis, 79000, Turkey (Türkiye)
NCT Number: NCT07673757
The purpose of this study is to evaluate the effect of therapeutic touch on pain intensity associated with intramuscular injection and to examine the relationship between fear of pain and injection-related pain. Participants are assigned to either a therapeutic touch group or a control group. Pain intensity is assessed using a Visual Analog Scale (VAS), and fear of pain is assessed using the Fear of Pain Questionnaire.
Looking for future studies?
Notify Me18 year–60 year
All sexes
Interventional
Not applicable
Kilis, 79000, Turkey (Türkiye)
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
This intervention involves supportive hand-holding by the patient's companion during the intramuscular injection. Immediately before the injection, the researcher briefly demonstrated to the companion how the hand should be held and provided simple guidance. During the injection, the companion held the patient's hand with both hands, offering a calm, silent, and emotionally supportive presence. The nurse was responsible only for administering the intramuscular injection and monitoring clinical safety; the nurse did not participate in the intervention itself. After the injection, the patient's pain level was assessed using the VAS scale based on self-report.
Other names: Therapeutic Touch
Time frame: Immediately after the intramuscular injection (within 2 minutes).
Kilis 7 Aralik University
Other
Effect of Therapeutic Touch on Intramuscular Injection Pain: A Randomized Controlled Trial
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06501456
Behavior, COVID-19
Ciudad Autónoma de Buenos Aire, Buenos Aires F.D., Argentina
View Trial DetailsNCT04333498
Behavior, Health Behavior
New York, United States
View Trial DetailsNCT04477252
Behavior, Brain Diseases
Sant Cugat del Vallès, Barcelona, Spain
View Trial DetailsNCT04656028
Adherence, Adherence, Medication
Moscow, Russia
View Trial Details